Subsequently, the efficacy of CD19 CAR-T cell therapy in SLE was evaluated in five patients with severe or drug-resistant SLE and achieved long-term drug-free remission (Mackensen et al., 2022). This evidence concerns the gene CD19 and systemic lupus erythematosus.